In the quest for personalized medicine, a new risk score based on proteins that circulate in blood plasma may more accurately predict cardiovascular events for patients with stable coronary heart ...

In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics a subsidiary of Amgen and collaborators ...